Synerga.Fund S.A.

Other monetary intermediation

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2010-11-18
Share capital
2,730,999.00 PLN
Activity description

Synerga.Fund S.A. is a Kraków-based joint-stock company listed on the GPW NewConnect market under the ticker SNG. The company operates in the field of cell therapies. It also publishes basic registration and capital data, as well as reporting and corporate documents.

Registered address
ul. Mogilska 65, 31-545 Kraków, Poland
Email
Electronic delivery address
AE:PL-21682-72339-BWDCU-30

Financials

Revenue history (in k)

From the notes

Current income tax (CIT due)$10,237

Filing timeliness

Financial statements were filed on time, on average 30 days early. All were audited by a statutory auditor.

  • 202508/07/2026
  • 202422/05/2025
  • 202302/07/2024
  • 202213/07/2023
  • 202108/07/2022
  • 202013/07/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Stock quotes

PLN 0.36
0.00 (0.00%)
0.360.360.370.3610:0012:0014:0016:00
Open
PLN 0.36
High
PLN 0.36
Low
PLN 0.36
Volume
6.53K
Avg. vol.
6.32K
Market cap
PLN 9.83M
P/E ratio
–
EPS
-PLN 0.04
Shares outstanding
27.31M
52-week
PLN 0.35 – 0.40
Dividend yield
–
Dividend
–
Ex dividend date
–
Exchange
NewConnect

Quarterly results

PeriodRevenueEBITNet profit
Q3 2026USD 4.05kUSD -6.75kUSD -6.75k
Q2 2026USD -40.52kUSD -2.97kUSD -3.24k
Q1 2026USD 29.71kUSD -6.48kUSD -6.48k
Q4 2025USD 18.83kUSD -16.07kUSD -16.32k

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Industry · Other monetary intermediation822 / 899
Top 91%
Sector · Real estate activities5,643 / 6,225
Top 91%
City · Kraków14,397 / 16,184
Top 89%
Voivodeship · Małopolskie25,140 / 27,774
Top 91%
Country · Poland269,840 / 297,566
Top 91%

Results vs industry

Revenue
This companyUSD 3.77kMedianUSD 280.61kAverageUSD 39.03m
Net profit
This companyUSD -283.22kMedianUSD 14.71kAverageUSD 7.93m
Operating costs
This companyUSD 30.85kMedianUSD 154.52kAverageUSD 16.64m
Assets
This companyUSD 7.75kMedianUSD 535.48kAverageUSD 527.97m

Authorized Representatives

Tomasz Wykurz age 49 – President of the Management Board

Manner of representation

The following are authorized to submit declarations of will on behalf of the company and sign declarations on behalf of the company: - the President of the Management Board acting independently; or - two members of the management board acting jointly; or - one member of the management board acting jointly with a commercial proxy.

Supervisory board

Artur Rzepka age 48 – Supervisory Board Member
Maciej Fersztorowski age 51 – Supervisory Board Member
Patrycja Ignacy age 37 – Supervisory Board Member
Iwona Stopa age 61 – Supervisory Board Member
Piotr Krupa age 45 – Supervisory Board Member

Beneficial owners

Synerga.Fund is a public company listed on NewConnect, so it does not report beneficial owners to the CRBR (Art. 58 of the Polish AML Act). Its shareholders are disclosed in stock-exchange reports.

Bank accounts

Registered as a VAT taxpayer on 2010-10-22.

Debt

No entries in the National Debtors Register (KRZ).

MSiG notices

Publication dateEvent
Oct 8, 2020Call to creditors
Sep 5, 2019Call to creditors
Dec 29, 2011Commercial Companies Code notice
Dec 6, 2011Commercial Companies Code notice

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name
Just Be Innovative sp. z o.o.
DR Joanna Sanford sp. k.
Cellis sp. z o.o.
4cell Therapies S.A.
Thesybin Labs P.S.A.
Oncotherics Poland S.A.
Bioinfobank Capital sp. z o.o.
Fusiomica sp. z o.o.
Spinbionic sp. z o.o.
Passio Human Microbiome sp. z o.o.

Change history

DateEvent
2026-10-30Address change
2020-10-07Share capital reduction
2019-12-13Share capital reduction
2019-11-21Address change
2017-08-17Address change

FAQ

Last updated: 2026-10-30